CMS Just Padlocked Medicare’s Front Door for Some Medical Supply Companies. Fraud Is Real. So Is Power Creep.

I spent part of yesterday in that classic American policy workshop: a fluorescent-lit corner of the public library, Federal Register open, printer toner in the air, civic dread on the menu. In my head: a senior with a walker, a kid with braces, a veteran with a CPAP. On screen: Washington trying to stop scams without jamming up care.

What CMS did (and when)

CMS imposed a six-month, nationwide moratorium on new Medicare enrollments for certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers, specifically the supplier category it calls medical supply company suppliers. The notice says it takes effect February 27, 2026 and applies across the United States, including territories and the District of Columbia.

• New businesses whose principal function is furnishing DMEPOS supplies cannot newly enroll under the covered supplier types during the moratorium.
• Existing enrolled suppliers that need a new initial enrollment (for example, a new practice location that requires separate enrollment) also hit a locked door for six months.
• Applications received by contractors before the effective date are not supposed to be swept into the ban.

CMS lists seven affected supplier types, all variations of “medical supply company,” including versions staffed with orthotics, pedorthics, prosthetics, combinations of those, and versions with a registered pharmacist or a respiratory therapist. CMS says it will closely screen applications during the moratorium to stop would-be medical supply companies from slipping in through another category, and it explicitly mentions site visits and online research. It also warns about long reapplication or reenrollment bars and referrals when suppliers submit false or misleading information.

The Orwell check: “moratorium” is a ban with nicer shoes

“Moratorium” is the polite noun. “Temporary” is the comforting adjective. Together they read like a sweater you put on so you do not notice the handcuffs.

Yes, CMS points to authority to impose temporary enrollment moratoria when it determines there is significant potential for fraud, waste, or abuse, and it has to explain itself in a Federal Register notice. That is the civics-textbook version. The lived version is a nationwide enrollment ban, even a narrow one, is a big lever.

The tradeoff and the liberty ledger

CMS frames this as a fraud move, not a benefit cut: existing suppliers can keep billing. Other kinds of suppliers that furnish DMEPOS but do not have DMEPOS as their principal function (like pharmacies and hospitals) are not the target. CMS also leaves room for states to decide how, or whether, to mirror a similar moratorium in Medicaid and CHIP.

Who gains freedom? Beneficiaries and taxpayers, if fewer scams get through. Honest providers, if scammers stop undercutting the market. Who loses freedom? Clean new entrants, for six months, and communities with thin supplier networks that rely on competition and choice. And the system takes on more executive discretion, especially because the notice acknowledges the moratorium can be extended in six-month increments.

Guardrails worth demanding

• Publish monthly metrics that justify the moratorium and track collateral damage.
• Provide a clear, fast appeal and correction path for legitimate suppliers caught in gray zones.
• Congress should demand oversight review from inspectors general and GAO on whether a nationwide moratorium beats more targeted tools.
• Put an exit ramp in writing: a public standard for lifting the moratorium, and real specificity for any extension.

Fraud is a tax on care. But so is unaccountable power. Are we going to demand the guardrails now, or pretend “temporary” always means what it says?